临床肝胆病杂志2018，Vol.34Issue(2)：233-237,5.DOI:10.3969/j.issn.1001-5256.2018.02.003
我国慢性丙型肝炎患者真实世界中直接抗病毒药物治疗方案的选择与评价
Selection and evaluation of treatment regimens with direct-acting antiviral agents for patients with chronic hepatitis C in the real world in China
安子英 1丁洋 1窦晓光1
作者信息
- 1. 中国医科大学附属盛京医院感染科,沈阳110022
- 折叠
摘要
Abstract
Chronic hepatitis C (CHC) is a chronic and progressive disease prevalent in the whole world and greatly threatens human health.The launch of direct-acting antiviral agents (DAAs) brings a revolutionary change in the treatment of CHC.In recent years,several DAAs have been marketed in foreign countries and have achieved good clinical effects,and in China,some DAAs have also been approved and widely used in clinical practice,which contributes to the increase in the cure rate of hepatitis C.This article analyzes the features,clinical effects,and indications of DAAs marketed in China and reviews published real-world studies,in order to help clinicians select proper treatment regimens based on patients' features.关键词
肝炎,丙型,慢性/抗病毒药/治疗/真实世界Key words
hepatitis C, chronic/antiviral agents/therapy/real-world分类
医药卫生引用本文复制引用
安子英,丁洋,窦晓光..我国慢性丙型肝炎患者真实世界中直接抗病毒药物治疗方案的选择与评价[J].临床肝胆病杂志,2018,34(2):233-237,5.
